IMMUNO-COV™ - Learn why this is a different kind of COVID-19 antibody test

Imanis Life Sciences

Menu

Interview with Vyraid and Imanis CEO

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, speaks with Stephen Russell, CEO of Vyriad. Dr. Russell reveals invaluable insights for those looking for or currently putting together partnership deals.

October 13, 2020, Imanis Life Sciences, Rochester MN

From Decision Resource Group

Stephen shares his journey from academia at the Mayo Clinic to founding Vyriad, and eventually partnering with Regeneron for the development of new oncolytic virus treatments for cancer. Learn how Vyriad pivoted their technology to develop antibody tests for COVID-19 during the crisis. Watch the full interview here.

Learning Resources

Stay Informed

Stay up to date on the latest from the Imanis team, including product releases, promotional codes, and exciting new advancements in noninvasive in vivo imaging!